Global Sustained Release Ocular Drug Delivery Systems Market Insights and Forecast to 2026

Global Sustained Release Ocular Drug Delivery Systems Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Sustained Release Ocular Drug Delivery Systems Product Introduction
1.2 Market Segments
1.3 Key Sustained Release Ocular Drug Delivery Systems Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Type
1.4.2 Liposome
1.4.3 Microcapsules/Nanocapsules
1.4.4 Microspheres/Nanosptheres
1.4.5 Implants
1.5 Market by Application
1.5.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Application
1.5.2 Cataract
1.5.3 Glaucoma
1.5.4 Corneal Transplantation
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size, Estimates and Forecasts
2.1.1 Global Sustained Release Ocular Drug Delivery Systems Revenue 2015-2026
2.1.2 Global Sustained Release Ocular Drug Delivery Systems Sales 2015-2026
2.2 Global Sustained Release Ocular Drug Delivery Systems, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Sustained Release Ocular Drug Delivery Systems Competitor Landscape by Players
3.1 Sustained Release Ocular Drug Delivery Systems Sales by Manufacturers
3.1.1 Sustained Release Ocular Drug Delivery Systems Sales by Manufacturers (2015-2020)
3.1.2 Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2015-2020)
3.2 Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturers
3.2.1 Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturers (2015-2020)
3.2.2 Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sustained Release Ocular Drug Delivery Systems Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sustained Release Ocular Drug Delivery Systems Revenue in 2019
3.2.5 Global Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sustained Release Ocular Drug Delivery Systems Price by Manufacturers
3.4 Sustained Release Ocular Drug Delivery Systems Manufacturing Base Distribution, Product Types
3.4.1 Sustained Release Ocular Drug Delivery Systems Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
3.4.3 Date of International Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)
4.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2015-2020)
4.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2015-2020)
4.1.3 Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Type (2021-2026)
4.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Type (2021-2026)
4.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Type (2021-2026)
4.2.3 Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sustained Release Ocular Drug Delivery Systems Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)
5.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2015-2020)
5.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2015-2020)
5.1.3 Sustained Release Ocular Drug Delivery Systems Price by Application (2015-2020)
5.2 Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Application (2021-2026)
5.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Application (2021-2026)
5.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Application (2021-2026)
5.2.3 Global Sustained Release Ocular Drug Delivery Systems Price Forecast by Application (2021-2026)
6 North America
6.1 North America Sustained Release Ocular Drug Delivery Systems by Country
6.1.1 North America Sustained Release Ocular Drug Delivery Systems Sales by Country
6.1.2 North America Sustained Release Ocular Drug Delivery Systems Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Type
6.3 North America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Application
7 Europe
7.1 Europe Sustained Release Ocular Drug Delivery Systems by Country
7.1.1 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country
7.1.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Type
7.3 Europe Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems by Region
8.1.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region
8.1.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Type
8.3 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Application
9 Latin America
9.1 Latin America Sustained Release Ocular Drug Delivery Systems by Country
9.1.1 Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country
9.1.2 Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Type
9.3 Central & South America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems by Country
10.1.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country
10.1.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Type
10.3 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Application
11 Company Profiles
11.1 pSivida
11.1.1 pSivida Corporation Information
11.1.2 pSivida Description and Business Overview
11.1.3 pSivida Sales, Revenue and Gross Margin (2015-2020)
11.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Products Offered
11.1.5 pSivida Related Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Description and Business Overview
11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Products Offered
11.2.5 Allergan Related Developments
11.3 Icon Bioscience
11.3.1 Icon Bioscience Corporation Information
11.3.2 Icon Bioscience Description and Business Overview
11.3.3 Icon Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Products Offered
11.3.5 Icon Bioscience Related Developments
11.4 Ocular Therapeutix
11.4.1 Ocular Therapeutix Corporation Information
11.4.2 Ocular Therapeutix Description and Business Overview
11.4.3 Ocular Therapeutix Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Products Offered
11.4.5 Ocular Therapeutix Related Developments
11.5 Neurotech Pharmaceuticals
11.5.1 Neurotech Pharmaceuticals Corporation Information
11.5.2 Neurotech Pharmaceuticals Description and Business Overview
11.5.3 Neurotech Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
11.5.5 Neurotech Pharmaceuticals Related Developments
11.6 Santen Pharmaceutical
11.6.1 Santen Pharmaceutical Corporation Information
11.6.2 Santen Pharmaceutical Description and Business Overview
11.6.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Products Offered
11.6.5 Santen Pharmaceutical Related Developments
11.7 Aciont Inc.
11.7.1 Aciont Inc. Corporation Information
11.7.2 Aciont Inc. Description and Business Overview
11.7.3 Aciont Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Products Offered
11.7.5 Aciont Inc. Related Developments
11.8 Envisia Therapeutics
11.8.1 Envisia Therapeutics Corporation Information
11.8.2 Envisia Therapeutics Description and Business Overview
11.8.3 Envisia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Products Offered
11.8.5 Envisia Therapeutics Related Developments
11.9 GrayBug
11.9.1 GrayBug Corporation Information
11.9.2 GrayBug Description and Business Overview
11.9.3 GrayBug Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Products Offered
11.9.5 GrayBug Related Developments
11.10 Innocore Pharmaceuticals
11.10.1 Innocore Pharmaceuticals Corporation Information
11.10.2 Innocore Pharmaceuticals Description and Business Overview
11.10.3 Innocore Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
11.10.5 Innocore Pharmaceuticals Related Developments
11.1 pSivida
11.1.1 pSivida Corporation Information
11.1.2 pSivida Description and Business Overview
11.1.3 pSivida Sales, Revenue and Gross Margin (2015-2020)
11.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Products Offered
11.1.5 pSivida Related Developments
11.12 PolyActiva
11.12.1 PolyActiva Corporation Information
11.12.2 PolyActiva Description and Business Overview
11.12.3 PolyActiva Sales, Revenue and Gross Margin (2015-2020)
11.12.4 PolyActiva Products Offered
11.12.5 PolyActiva Related Developments
11.13 TheraKine
11.13.1 TheraKine Corporation Information
11.13.2 TheraKine Description and Business Overview
11.13.3 TheraKine Sales, Revenue and Gross Margin (2015-2020)
11.13.4 TheraKine Products Offered
11.13.5 TheraKine Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Sustained Release Ocular Drug Delivery Systems Market Estimates and Projections by Region
12.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Regions 2021-2026
12.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Regions 2021-2026
12.2 North America Sustained Release Ocular Drug Delivery Systems Market Size Forecast (2021-2026)
12.2.1 North America: Sustained Release Ocular Drug Delivery Systems Sales Forecast (2021-2026)
12.2.2 North America: Sustained Release Ocular Drug Delivery Systems Revenue Forecast (2021-2026)
12.2.3 North America: Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Country (2021-2026)
12.3 Europe Sustained Release Ocular Drug Delivery Systems Market Size Forecast (2021-2026)
12.3.1 Europe: Sustained Release Ocular Drug Delivery Systems Sales Forecast (2021-2026)
12.3.2 Europe: Sustained Release Ocular Drug Delivery Systems Revenue Forecast (2021-2026)
12.3.3 Europe: Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sustained Release Ocular Drug Delivery Systems Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sustained Release Ocular Drug Delivery Systems Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Region (2021-2026)
12.5 Latin America Sustained Release Ocular Drug Delivery Systems Market Size Forecast (2021-2026)
12.5.1 Latin America: Sustained Release Ocular Drug Delivery Systems Sales Forecast (2021-2026)
12.5.2 Latin America: Sustained Release Ocular Drug Delivery Systems Revenue Forecast (2021-2026)
12.5.3 Latin America: Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sustained Release Ocular Drug Delivery Systems Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sustained Release Ocular Drug Delivery Systems Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Sustained Release Ocular Drug Delivery Systems Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sustained Release Ocular Drug Delivery Systems Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Sustained Release Ocular Drug Delivery Systems Market Segments
Table 2. Ranking of Global Top Sustained Release Ocular Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Liposome
Table 5. Major Manufacturers of Microcapsules/Nanocapsules
Table 6. Major Manufacturers of Microspheres/Nanosptheres
Table 7. Major Manufacturers of Implants
Table 8. Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Sustained Release Ocular Drug Delivery Systems Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Sustained Release Ocular Drug Delivery Systems Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Regions (2015-2020)
Table 12. Global Sustained Release Ocular Drug Delivery Systems Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturers (2015-2020)
Table 15. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2019)
Table 17. Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Sustained Release Ocular Drug Delivery Systems Price (2015-2020) (USD/Pcs)
Table 20. Sustained Release Ocular Drug Delivery Systems Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table 22. Date of International Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2015-2020) (K Pcs)
Table 25. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2015-2020)
Table 26. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2015-2020)
Table 28. Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2015-2020) (K Pcs)
Table 30. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2015-2020)
Table 31. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2015-2020) (K Pcs)
Table 32. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 33. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 35. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2015-2020) (K Pcs)
Table 36. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 37. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2015-2020) (K Pcs)
Table 38. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 39. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 41. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 43. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 45. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 55. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 59. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 61. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 71. pSivida Corporation Information
Table 72. pSivida Description and Major Businesses
Table 73. pSivida Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. pSivida Product
Table 75. pSivida Recent Development
Table 76. Allergan Corporation Information
Table 77. Allergan Description and Major Businesses
Table 78. Allergan Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Allergan Product
Table 80. Allergan Recent Development
Table 81. Icon Bioscience Corporation Information
Table 82. Icon Bioscience Description and Major Businesses
Table 83. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Icon Bioscience Product
Table 85. Icon Bioscience Recent Development
Table 86. Ocular Therapeutix Corporation Information
Table 87. Ocular Therapeutix Description and Major Businesses
Table 88. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Ocular Therapeutix Product
Table 90. Ocular Therapeutix Recent Development
Table 91. Neurotech Pharmaceuticals Corporation Information
Table 92. Neurotech Pharmaceuticals Description and Major Businesses
Table 93. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Neurotech Pharmaceuticals Product
Table 95. Neurotech Pharmaceuticals Recent Development
Table 96. Santen Pharmaceutical Corporation Information
Table 97. Santen Pharmaceutical Description and Major Businesses
Table 98. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Santen Pharmaceutical Product
Table 100. Santen Pharmaceutical Recent Development
Table 101. Aciont Inc. Corporation Information
Table 102. Aciont Inc. Description and Major Businesses
Table 103. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Aciont Inc. Product
Table 105. Aciont Inc. Recent Development
Table 106. Envisia Therapeutics Corporation Information
Table 107. Envisia Therapeutics Description and Major Businesses
Table 108. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Envisia Therapeutics Product
Table 110. Envisia Therapeutics Recent Development
Table 111. GrayBug Corporation Information
Table 112. GrayBug Description and Major Businesses
Table 113. GrayBug Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. GrayBug Product
Table 115. GrayBug Recent Development
Table 116. Innocore Pharmaceuticals Corporation Information
Table 117. Innocore Pharmaceuticals Description and Major Businesses
Table 118. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Innocore Pharmaceuticals Product
Table 120. Innocore Pharmaceuticals Recent Development
Table 121. OHR Pharmaceuticals Corporation Information
Table 122. OHR Pharmaceuticals Description and Major Businesses
Table 123. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. OHR Pharmaceuticals Product
Table 125. OHR Pharmaceuticals Recent Development
Table 126. PolyActiva Corporation Information
Table 127. PolyActiva Description and Major Businesses
Table 128. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 129. PolyActiva Product
Table 130. PolyActiva Recent Development
Table 131. TheraKine Corporation Information
Table 132. TheraKine Description and Major Businesses
Table 133. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 134. TheraKine Product
Table 135. TheraKine Recent Development
Table 136. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Regions (2021-2026) (K Pcs)
Table 137. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Regions (2021-2026)
Table 138. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 139. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Regions (2021-2026)
Table 140. North America: Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2021-2026) (K Pcs)
Table 141. North America: Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Europe: Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2021-2026) (K Pcs)
Table 143. Europe: Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Asia Pacific: Sustained Release Ocular Drug Delivery Systems Sales Forecast by Region (2021-2026) (K Pcs)
Table 145. Asia Pacific: Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Region (2021-2026) (US$ Million)
Table 146. Latin America: Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. Latin America: Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Middle East and Africa: Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2021-2026) (K Pcs)
Table 149. Middle East and Africa: Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 151. Key Challenges
Table 152. Market Risks
Table 153. Main Points Interviewed from Key Sustained Release Ocular Drug Delivery Systems Players
Table 154. Sustained Release Ocular Drug Delivery Systems Customers List
Table 155. Sustained Release Ocular Drug Delivery Systems Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Sustained Release Ocular Drug Delivery Systems Product Picture
Figure 2. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2020 & 2026
Figure 3. Liposome Product Picture
Figure 4. Microcapsules/Nanocapsules Product Picture
Figure 5. Microspheres/Nanosptheres Product Picture
Figure 6. Implants Product Picture
Figure 7. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2020 & 2026
Figure 8. Cataract
Figure 9. Glaucoma
Figure 10. Corneal Transplantation
Figure 11. Others
Figure 12. Sustained Release Ocular Drug Delivery Systems Report Years Considered
Figure 13. Global Sustained Release Ocular Drug Delivery Systems Market Size 2015-2026 (US$ Million)
Figure 14. Global Sustained Release Ocular Drug Delivery Systems Sales 2015-2026 (K Pcs)
Figure 15. Global Sustained Release Ocular Drug Delivery Systems Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2015-2020)
Figure 17. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region in 2019
Figure 18. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2015-2020)
Figure 19. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region in 2019
Figure 20. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Sustained Release Ocular Drug Delivery Systems Revenue in 2019
Figure 22. Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Figure 24. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019
Figure 25. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2015-2020)
Figure 26. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type in 2019
Figure 27. Global Sustained Release Ocular Drug Delivery Systems Market Share by Price Range (2015-2020)
Figure 28. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Figure 29. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019
Figure 30. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2015-2020)
Figure 31. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application in 2019
Figure 32. North America Sustained Release Ocular Drug Delivery Systems Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country in 2019
Figure 35. North America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country in 2019
Figure 36. U.S. Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Sustained Release Ocular Drug Delivery Systems Market Share by Type in 2019
Figure 41. North America Sus

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Artificial Tears Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91

Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......

Global Contact Lens Solution Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96

Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......

Global Latanoprost Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......

Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......

Global Dry Eye Syndrome Drugs Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82

The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......

Global Eye Drops & Lubricants Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......

Global Conjunctivitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......

Global Contact Lens Solution Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118

According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......

Global Latanoprost Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs